KROS Keros Therapeutics, Inc.
Biotechnology NasdaqGM
Trading Signals
Overall Signal
SELL
Strong sellish signal based on multiple indicators.
Key Price Levels
Support Levels
- Strong Support $12.37
- Medium Support $12.74
- Weak Support $13.12
Resistance Levels
- Weak Resistance $13.86
- Medium Resistance $14.24
- Strong Resistance $14.61
Stop Loss Suggestions
- Conservative $14.23
- Moderate $14.05
- Aggressive $14.43
Analyst Ratings
Current Rating
Last Month
2 Months Ago
3 Months Ago
Signal Indicator
| Indicator | Signal | Strength | Timeframe |
|---|---|---|---|
| Moving Averages | NEUTRAL |
|
Short & Medium Term |
| Oscillators | SELL |
|
Short Term |
| Trend Indicators | SELL |
|
Short & Medium Term |
| Volume Indicators | SELL |
|
Short & Medium Term |
| Support/Resistance | NEUTRAL |
|
Short Term |
Stock Price Prediction Price Target Probabilities
Quarterly Outlook
2025-07-01
Bullish Scenario
from current 35.73%
Strong upward momentum and confirmed bullish trend, with potential for significant price appreciation. Indicators point to sustained buying pressure. ADX (23.89) indicates a developing or moderate trend. -DI > +DI suggests bearish directional bias. RSI (37.65) is in bearish territory, indicating downward momentum. MACD line (-3.96) is above Signal line (-5.45) (bullish crossover), confirming upward momentum. Current Weekly ATR is 2.41, indicating the average weekly price range.
2025-07-01
Base Scenario
from current -2.55%
Price is likely to continue its moderate trajectory, reflecting underlying market conditions and historical volatility. Indicators suggest a balanced outlook. ADX (23.89) indicates a developing or moderate trend. -DI > +DI suggests bearish directional bias. RSI (37.65) is in bearish territory, indicating downward momentum. MACD line (-3.96) is above Signal line (-5.45) (bullish crossover), confirming upward momentum. Current Weekly ATR is 2.41, indicating the average weekly price range.
2025-07-01
Bearish Scenario
from current -35.73%
Increased selling pressure and potential for a significant price correction or downtrend. Indicators suggest waning bullish momentum or strengthening bearish forces. ADX (23.89) indicates a developing or moderate trend. -DI > +DI suggests bearish directional bias. RSI (37.65) is in bearish territory, indicating downward momentum. MACD line (-3.96) is above Signal line (-5.45) (bullish crossover), confirming upward momentum. Current Weekly ATR is 2.41, indicating the average weekly price range.
Annual Outlook
2025-07-01
Bullish Scenario
from current 71.46%
Long-term bullish trend with strong fundamental catalysts and sustained institutional buying. Expect significant capital appreciation over the year. ADX (23.89) indicates a developing or moderate trend. -DI > +DI suggests bearish directional bias. RSI (37.65) is in bearish territory, indicating downward momentum. MACD line (-3.96) is above Signal line (-5.45) (bullish crossover), confirming upward momentum. Current Weekly ATR is 2.41, indicating the average weekly price range.
2025-07-01
Base Scenario
from current -5.1%
Steady long-term growth consistent with market and industry averages. Price expected to follow a typical growth trajectory. ADX (23.89) indicates a developing or moderate trend. -DI > +DI suggests bearish directional bias. RSI (37.65) is in bearish territory, indicating downward momentum. MACD line (-3.96) is above Signal line (-5.45) (bullish crossover), confirming upward momentum. Current Weekly ATR is 2.41, indicating the average weekly price range.
2025-07-01
Bearish Scenario
from current -71.46%
Long-term bearish trend with significant headwinds from economic factors, industry disruption, or company-specific issues. Expect notable price depreciation. ADX (23.89) indicates a developing or moderate trend. -DI > +DI suggests bearish directional bias. RSI (37.65) is in bearish territory, indicating downward momentum. MACD line (-3.96) is above Signal line (-5.45) (bullish crossover), confirming upward momentum. Current Weekly ATR is 2.41, indicating the average weekly price range.
Technical Analysis
Trend Identification
EMA
Exponential Moving Average
Current price (13.49) is below both Short MA (13.99) and Long MA (13.57). This indicates strong bearish momentum. Short MA (13.99) is above Long MA (13.57), a bullish crossover ('Golden Cross' if it's a significant period). This indicates an upward trend. MAs (13.99, 13.57, 12.55) show mixed alignment, suggesting market indecision or range-bound activity.
MACD
Moving Average Convergence Divergence
MACD line is below the Signal line (bearish crossover). This indicates downward momentum. Histogram (-0.0700) is negative and expanding, confirming bearish momentum. Both MACD and Signal lines are below the zero line, reinforcing bearish momentum (bearish territory). This is a strong sell signal. Consider short positions.
ADX
Average Directional Index
ADX (18.91) indicates a weak or non-existent trend (ranging market). -DI (21.77) is above +DI (15.57), suggesting a bearish directional bias. Avoid trend-following strategies. Consider range-bound or reversal strategies, or wait for a clearer trend to develop.
Momentum Measurement
RSI
Relative Strength Index
RSI (43.04) is in the bearish territory, but not yet oversold. This indicates downward momentum. Monitor for continuation or signs of strength.
OBV
On-Balance Volume
OBV (-10791879.00) is falling, indicating selling pressure and distribution. Price is falling and OBV is falling. This is bearish confirmation, indicating selling pressure supports the price decrease. Consider holding short positions or initiating new ones. Volume is supporting the trend.
Stochastic
Stochastic Oscillator
Stochastics (%K: 27.67, %D: 43.17) are in the neutral zone (between 20 and 80). A bearish crossover (%K below %D) is observed. This indicates downward momentum. Be cautious if it's already in the oversold region.
CCI
Commodity Channel Index
CCI (-77.04) is between -100 and 0. This indicates bearish momentum is present, but not yet extreme. A move below 0 from positive territory (bearish zero-line cross) can indicate a potential sell signal.
Volatility Measurement
ATR
Average True Range
Current ATR is 0.4700. ATR indicates average volatility. Market conditions are relatively stable.
Bollinger Bands
Volatility Bands
Current price (13.49) is within the Bollinger Bands (12.86 - 15.12). This suggests the price is trading within its typical volatility range. Price is below the Middle Band (13.99), indicating short-term bearish bias. Bollinger Bands are wide. This indicates high volatility. Prices tend to revert to the mean after extended periods of high volatility.
Risk Management & Potential Reversals
SAR
Parabolic Stop and Reverse
SAR points above price indicate bearish trend. Current SAR at 14.23 is 5.49% from price. Consider SAR as a potential take-profit level or to confirm a downtrend.
RSI
Reversal Perspective
Current RSI level is in neutral territory. No RSI divergence detected. Current RSI level doesn't suggest imminent reversal.
Stochastic
Approaching Oversold
Stochastic is approaching oversold territory (27.7). No reversal signal yet. Monitor for potential bullish crossover (K above D) or entry into oversold (20-) followed by reversal. Current crossover status: Bearish.
Bollinger Bands
Reversal Perspective
Bollinger Bands are widening, indicating high volatility and potential strong trend continuation.Price is in the lower half of the bands, suggesting a bearish bias.No indication of imminent volatility expansion or reversal.
Holder List (Top 20)
| Holder Name | Holder Type | Shares | Pct. Held | Date Reported |
|---|---|---|---|---|
| Nuveen, LLC | INSTITUTIONAL | 3947455 | 9.72% | 2025-03-31 |
| Blackrock Inc. | INSTITUTIONAL | 2785237 | 6.86% | 2025-03-31 |
| JPMORGAN CHASE & CO | INSTITUTIONAL | 2600457 | 6.4% | 2025-03-31 |
| Vanguard Group Inc | INSTITUTIONAL | 2566321 | 6.32% | 2025-03-31 |
| Logos Global Management LP | INSTITUTIONAL | 2000000 | 4.92% | 2025-03-31 |
| Morgan Stanley | INSTITUTIONAL | 1697557 | 4.18% | 2025-03-31 |
| Nantahala Capital Management, LLC | INSTITUTIONAL | 1506790 | 3.71% | 2025-03-31 |
| Adar1 Capital Management, LLC | INSTITUTIONAL | 1486461 | 3.66% | 2025-03-31 |
| State Street Corporation | INSTITUTIONAL | 1302539 | 3.21% | 2025-03-31 |
| Shaw D.E. & Co., Inc. | INSTITUTIONAL | 1263130 | 3.11% | 2025-03-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | MUTUALFUND | 1017145 | 2.5% | 2025-03-31 |
| iShares Trust-iShares Russell 2000 ETF | MUTUALFUND | 818015 | 2.01% | 2025-04-30 |
| SPDR SERIES TRUST-SPDR(R) S&P(R) Biotech ETF | MUTUALFUND | 661446 | 1.63% | 2025-04-30 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | MUTUALFUND | 576799 | 1.42% | 2025-03-31 |
| ACAP Strategic Fund | MUTUALFUND | 419586 | 1.03% | 2025-03-31 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | MUTUALFUND | 308391 | 0.76% | 2025-02-28 |
| iShares Trust-iShares Russell 2000 Growth ETF | MUTUALFUND | 291237 | 0.72% | 2025-04-30 |
| Fidelity Select Portfolios-Biotechnology Portfolio | MUTUALFUND | 243078 | 0.6% | 2025-04-30 |
| VANGUARD EXPLORER FUND | MUTUALFUND | 215561 | 0.53% | 2025-01-31 |
| iShares Trust-iShares Biotechnology ETF | MUTUALFUND | 209640 | 0.52% | 2025-04-30 |